Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1108640.RAJu9q92CpDSip-lRpCCkJy50Afwf9bMhTh9YXZqWAzP8130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1108640.RAJu9q92CpDSip-lRpCCkJy50Afwf9bMhTh9YXZqWAzP8130_assertion type Assertion NP1108640.RAJu9q92CpDSip-lRpCCkJy50Afwf9bMhTh9YXZqWAzP8130_head.
- NP1108640.RAJu9q92CpDSip-lRpCCkJy50Afwf9bMhTh9YXZqWAzP8130_assertion description "[Although overexpression of angiotensin-converting enzyme type 2 (ACE2) has been shown to be beneficial in reducing hypertension by transforming angiotensin II into angiotensin-(1-7), several groups have reported decreased brain ACE2 expression and activity during the development of hypertension.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1108640.RAJu9q92CpDSip-lRpCCkJy50Afwf9bMhTh9YXZqWAzP8130_provenance.
- NP1108640.RAJu9q92CpDSip-lRpCCkJy50Afwf9bMhTh9YXZqWAzP8130_assertion evidence source_evidence_literature NP1108640.RAJu9q92CpDSip-lRpCCkJy50Afwf9bMhTh9YXZqWAzP8130_provenance.
- NP1108640.RAJu9q92CpDSip-lRpCCkJy50Afwf9bMhTh9YXZqWAzP8130_assertion SIO_000772 24014829 NP1108640.RAJu9q92CpDSip-lRpCCkJy50Afwf9bMhTh9YXZqWAzP8130_provenance.
- NP1108640.RAJu9q92CpDSip-lRpCCkJy50Afwf9bMhTh9YXZqWAzP8130_assertion wasDerivedFrom befree-2016 NP1108640.RAJu9q92CpDSip-lRpCCkJy50Afwf9bMhTh9YXZqWAzP8130_provenance.
- NP1108640.RAJu9q92CpDSip-lRpCCkJy50Afwf9bMhTh9YXZqWAzP8130_assertion wasGeneratedBy ECO_0000203 NP1108640.RAJu9q92CpDSip-lRpCCkJy50Afwf9bMhTh9YXZqWAzP8130_provenance.